Mechlorethamine: Clinical Trials

9 trials of Mechlorethamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 unknown. 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 29Completed 8, Unknown 1

Follow Mechlorethamine: new trials by email Literature Review of Mechlorethamine trials Research Report on Mechlorethamine

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Valchlor in the Treatment of Lichen Planopilaris
Mechlorethamine 0.016% Top Gel - Lichen Planopilaris
Phase 2CompletedMayo Clinic122018-04-012021-01-28
Mechlorethamine Induced Contact Dermatitis Avoidance Study
Triamcinolone, Valchlor 0.016 % Topical Gel - Cutaneous T-cell Lymphoma, Cutaneous T-cell Lymphoma Stage I
Phase 2CompletedRochester Skin Lymphoma Medical Group, PLLC282017-12-132026-09-04
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
cyclophosphamide, cyclosporine, fludarabine phosphate - Lymphoma
Phase 2CompletedMemorial Sloan Kettering Cancer Center252007-11-132023-09-28
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
Adriamycin®, Vinblastine, Nitrogen Mustard - Hodgkin's Lymphoma
Phase 2CompletedSt. Jude Children's Research Hospital812006-07-202023-09-22
Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
mechlorethamine-MCH (nitrogen mustard) - Mycosis Fungoides
Phase 2CompletedYaupon Therapeutics2602006-05-012012-10-31
Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection
bleomycin sulfate, filgrastim, Stanford V regimen - Lymphoma
Phase 2UnknownCentro di Riferimento Oncologico - Aviano301997-05-012013-09-20
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease
bleomycin sulfate, Stanford V regimen, doxorubicin hydrochloride - Lymphoma
Phase 2CompletedStanford University1995-04-012013-05-15
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
Bleomycin sulfate, Stanford V regimen, Doxorubicin hydrochloride - Lymphoma
Phase 2CompletedStanford University501989-04-012020-08-12
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
MOPP Regimen, Leucovorin Calcium, Mechlorethamine Hydrochloride - Brain and Central Nervous System Tumors
Phase 2CompletedM.D. Anderson Cancer Center41989-02-012013-02-18

Conditions studied

Hodgkin Disease (5)  ·  Lymphoma (4)  ·  Lymphoma, T-Cell, Cutaneous (2)  ·  Mycosis Fungoides (2)  ·  Astrocytoma (1)  ·  Central Nervous System Neoplasms (1)  ·  Dermatitis, Contact (1)  ·  Lichen Planus (1)  ·  Recurrence (1)

Sponsors

Stanford University (2)  ·  Centro di Riferimento Oncologico - Aviano (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Rochester Skin Lymphoma Medical Group, PLLC (1)  ·  St. Jude Children's Research Hospital (1)  ·  Yaupon Therapeutics (1)

Countries

United States (8)  ·  Italy (1)

Top investigators

Sandra J. Horning, MD (2)  ·  Brian Poligone, MD, PhD (1)  ·  Jamie Flerlage, MD (1)  ·  Jason Sluzevich, MD (1)  ·  Joann Ater, MD (1)  ·  Juliet Barker, MBBS (1)  ·  Miguel-Angel Perales, MD (1)  ·  Stuart Lessin, M.D. (1)  ·  Tanya Trippett, MD (1)  ·  Umberto Tirelli, MD (1)

Results publications

PMID 23069814, PMID 34091453, PMID 35122614, PMID 35536441, PMID 37802679, PMID 7537796, PMID 8836420

NIH funding

P30CA016672 (1)